{"id":62299,"date":"2024-12-03T12:04:44","date_gmt":"2024-12-03T12:04:44","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/12\/03\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/"},"modified":"2024-12-03T12:04:44","modified_gmt":"2024-12-03T12:04:44","slug":"chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/","title":{"rendered":"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit"},"content":{"rendered":"<div>\n<p align=\"center\"><em>\u2014Movers in Rare Disease Summit Will Include Elevator Pitches from Rare Disease Companies<br \/><\/em><em>with \u201c<\/em>Key, Near-Term, Potentially Stock-Moving Catalysts\u201d\u2014<\/p>\n<p>TEL AVIV, Israel, Dec.  03, 2024  (GLOBE NEWSWIRE) &#8212; Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it will participate in Oppenheimer&#8217;s Movers in Rare Disease Summit on Thursday, December 12, 2024, at the Westin Grand Central in New York City. The invitation-only Rare Disease Summit will feature a day of panels, presentations and 1-on-1 investor meetings with companies working in the rare disease space.<\/p>\n<p>Chemomab management will present an Elevator Pitch and will be available for one-on-one meetings with registered attendees.\u00a0<\/p>\n<p><strong>Oppenheimer Movers in Rare Disease Summit<br \/><\/strong><\/p>\n<p><strong>Date:\u00a0<\/strong>December 12, 2024<\/p>\n<p><strong>Time of Elevator Pitch:\u00a0<\/strong>2:45-3:30 pm EST<\/p>\n<p><strong>Location:\u00a0<\/strong>Westin Grand Central, New York, NY<\/p>\n<p><strong>Format:\u00a0<\/strong> Elevator Pitch &amp; 1&#215;1 Meetings<\/p>\n<p>Please contact your Oppenheimer representative to register for the Rare Disease Summit and to schedule a 1&#215;1 meeting with Chemomab management.<\/p>\n<p><strong>About Chemomab Therapeutics Ltd.<\/strong><br \/>Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a first-in-class dual activity monoclonal antibody that neutralizes CCL24 and has demonstrated disease-modifying potential. In clinical and preclinical studies, CM-101 has been shown to have a favorable safety profile and has been generally well-tolerated, with the potential to treat multiple severe and life-threatening fibro-inflammatory diseases. Chemomab has reported positive results from four clinical trials of CM-101 in patients. Based on recent promising data from its Phase 2 SPRING trial in the rare liver disease primary sclerosing cholangitis (PSC), the company expects two milestones in early 2025 &#8212; FDA feedback on the design of its planned CM-101 PSC registrational trial and data from the SPRING trial open label extension. CM-101 has received FDA and EMA Orphan Drug and FDA Fast Track designations for the treatment of PSC. Chemomab\u2019s CM-101 program for the treatment of systemic sclerosis is Phase 2-ready with an open U.S. IND. For more information, visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iwJ2-oz8cuae2u1gPUKvQbWT5DwB73OvNLrK5lEgIepvaHbu639lr1I4y7Z5P_smCKJXD4hBDwXxmt9acaQBGQ==\" rel=\"nofollow\" target=\"_blank\" title=\"chemomab.com\">chemomab.com<\/a>.<\/p>\n<p><strong>Contacts:<\/strong><\/p>\n<p><strong>Media and Investors<\/strong>:<br \/>Barbara Lindheim<br \/>Consulting Vice President, Investor &amp; Public Relations, <br \/>Strategic Communications<br \/>Phone: +1 917-355-9234<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1LL9YWj8goxlZzR98zyX-5NhGr9yPQiQlMDtNZQ4Rdw5DSpEKXQOrGtb1gQNFGL30e3D6a05y0NQo35Tc8W7vrJJBWyKqIRfGFEhe10P8b-tjNxJrMwGDU82acyUaLkt\" rel=\"nofollow\" target=\"_blank\" title=\"barbara.lindheim@chemomab.com\">barbara.lindheim@chemomab.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Em7BF610licHivqRAuKZWquUrd_3EGzVzsdi0RPa5cexvtQGE7lWZyxb_vaUcn_H4vxmQnbq3mfWtg-adWCDig==\" rel=\"nofollow\" target=\"_blank\" title=\"IR@chemomab.com\">IR@chemomab.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTk5OWRjZjMtMTgwZi00M2ZiLWIwOGUtMzM0ODRlNzA0NTk0LTEyOTc0Mjg=\/tiny\/Chemomab-Therapeutics.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u2014Movers in Rare Disease Summit Will Include Elevator Pitches from Rare Disease Companieswith \u201cKey, Near-Term, Potentially Stock-Moving Catalysts\u201d\u2014 TEL AVIV, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) &#8212; Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it will participate in [&#8230;]\n","protected":false},"author":1,"featured_media":62300,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-62299","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit\" \/>\n<meta property=\"og:description\" content=\"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-03T12:04:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/12\/Chemomab-Therapeutics.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit\",\"datePublished\":\"2024-12-03T12:04:44+00:00\",\"dateModified\":\"2024-12-03T12:04:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/\"},\"wordCount\":385,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/\",\"name\":\"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-12-03T12:04:44+00:00\",\"dateModified\":\"2024-12-03T12:04:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/","og_locale":"en_US","og_type":"article","og_title":"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit","og_description":"\u2014Movers in Rare Disease Summit Will Include Elevator Pitches from Rare Disease Companieswith \u201cKey, Near-Term, Potentially Stock-Moving Catalysts?","og_url":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-12-03T12:04:44+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/12\/Chemomab-Therapeutics.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit","datePublished":"2024-12-03T12:04:44+00:00","dateModified":"2024-12-03T12:04:44+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/"},"wordCount":385,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/","url":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/","name":"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-12-03T12:04:44+00:00","dateModified":"2024-12-03T12:04:44+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/chemomab-to-participate-in-oppenheimers-movers-in-rare-disease-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Chemomab to Participate in Oppenheimer\u2019s Movers in Rare Disease Summit"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/62299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=62299"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/62299\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/62300"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=62299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=62299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=62299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}